Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
No excess of mitochondrial DNA deletions within muscle in progressive multiple sclerosis.
In multiple sclerosis oligoclonal bands connect to peripheral B cell responses.
Vitamin D status and ill health: a systematic review.
Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.
Biogen Idec to present new two-year data from the PLEGRIDY™ (peginterferon beta-1a) Phase III advance study at AAN annual meeting
Is natalizumab overshooting its rebound?
Effects of the Anti-Multiple Sclerosis Immunomodulator Laquinimod on Anxiety and Depression in Rodent Behavioral Models.
Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial.
Assessing upper limb function in multiple sclerosis.
Self-Reported Fatigue and Energy Cost During Walking Are Not Related in Patients With Multiple Sclerosis.
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients.
Cyclophosphamide so-so verdict in progressive MS
Progressive multifocal leukoencephalopathy: new concepts.
FDA approval of Isentress (raltegravir)
Warner Chilcott sells Vectrin product line to Medicis
Identifying the Start of Multiple Sclerosis Injury: A Serial DTI Study.
Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis - a multicentre cohort study.
Presumptive Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis after Natalizumab Therapy.
The pathology of multiple sclerosis.
Neuropsychological Aspects of Childhood Multiple Sclerosis: An Overview.
Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
Epstein-Barr virus, latitude and multiple sclerosis.
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survival.
Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination.
Pages
« first
‹ previous
…
198
199
200
201
202
203
204
205
206
…
next ›
last »